newsfilter
← Latest News
GlobeNewswire·

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

ALPS
  • Alps Group Inc announced its subsidiary MyGenome Sdn. Bhd. received MS ISO 15189:2022 accreditation for Whole Genome Sequencing (WGS).
  • The MS ISO 15189:2022 standard represents an internationally recognized benchmark for quality & competence in medical laboratories.
  • MyGenome's WGS process covers a patient's complete DNA sequence rather than targeted genetic panels.
  • The accreditation validates that MyGenome's genomic data meets accuracy, reproducibility, & reliability benchmarks for clinical use & research integration.
  • This milestone positions MyGenome among a select group of Southeast Asian genomics laboratories operating WGS under this standard.
  • The certification expands Alps' addressable market to include government-linked healthcare programs, cross-border partnerships, & institutional clients.
  • Dr. Tham Seng Kong, Executive Director & CEO of Alps Group Inc, stated the accreditation confirms the clinical infrastructure is globally credible & clinically actionable.
  • Alps Group Inc is a revenue-generating integrated biotechnology platform headquartered in Malaysia operating in cell manufacturing, molecular diagnostics, & clinical delivery.
  • The company leverages revenue from commercial businesses to support clinical pipeline development with a mission to advance precision medicine across Southeast Asia.
  • The press release includes standard forward-looking statement disclaimers regarding uncertainties, risks, & future performance expectations.